"While these findings will understandably be welcomed by those living with obesity and looking for safe and effective treatments, given the recent spike in popularity related to the benefits of the GLP-1 treatment with global and high-profile celebrities commenting on its success, global demand has increased and resulted in a worldwide shortage of the drug." Prevalence of Obesity Among Cancer Patients According to the World Health Organization, 13% of adults worldwide are obese, a condition associated with an increased risk of developing cancer
En pacientes previamente tratados con metformina y/o sulfonilureas la adicin de por lo menos 3 aos con GLP1-RA, evidencindose una mejora de marcadores lipdicos como triacilglicridos (-12%), colesterol total (-5%), LDL (-6%) y HDL (+24%) 149
But the truth is, some have found success with a different approach: GLP-1 medications
TMAO reduces synaptic plasticity and induces cognitive dysfunction by promoting endoplasmic reticulum stress and directly binding to activate PERK, which damages synaptic plasticity (Zhang et al., 2007
You may know which protein options are easiest